EU HTA Regulation

Navigate Joint Clinical Assessments (JCA) with confidence

Navigate the complex and evolving European HTA landscape with Lumanity

Health Technology Assessment (HTA) in Europe has undergone its biggest shake-up in a generation. Moving toward a centralized approach across its member states, the European Commission has implemented joint clinical assessment (JCA) of health technologies in the European Union (EU), fundamentally changing the way new medical advances and innovations are brought to market in the EU. From 12 January 2025 the EU HTA Regulation began to apply to new oncology products, advanced therapy medicinal products (ATMP), and selected medical devices. The Regulation will apply to other products based on an agreed timeline.

Standardizing HTA across 27 countries with a combined population of over 400 million people is unprecedented in history, and the path to this point has been complex and challenging. Lumanity has been tracking developments on the EU HTA Regulation since its inception, taking part in the public consultations and attending stakeholders’ meetings. Since then, we have been committed to expanding our experience by delivering an extensive range of EU HTA Regulation projects.

Contact us for support preparing for joint clinical assessment, from training programmes and business readiness plans, to PICO simulations, evidence generation, and dossier writing, our team is here to help.

Contact us >

Our Perspectives on the EU HTA Regulation View all perspectives
Let's Talk

Get in touch with our EU HTA Regulation experts to see how we can support you.

Contact us >

Suzette Matthijsse MSc, PhD Senior Director, Strategic Advisory Services, HEOR
Read more about Suzette Matthijsse
Julie Roiz Senior Vice President & Global Head of Consulting, HEOR
Read more about Julie Roiz
Sallie Latimer Vice President & Global Head of Research, HEOR
Read more about Sallie Latimer
Get In Touch

Lumanity is the only global HEOR consultancy to have taken part in the EU HTA Regulation consultations over the past few years, and we have a deep and embedded knowledge of the Regulation.

Whether you need assistance preparing your business, training your teams, or guiding a product through joint clinical assessment, we are here to help.

"*" indicates required fields